Is Soleno Therapeutics, Inc. (SLNO) The Cheap Healthcare Stock To Buy Heading Into 2026?

Soleno Therapeutics, Inc. (NASDAQ:SLNO) is among the cheap healthcare stocks to bargain heading into 2026. As of December 7, Soleno Therapeutics, Inc. (NASDAQ:SLNO) has a statement Buy rating, arsenic each 13 analysts covering the banal person assigned a ‘Buy’ oregon equivalent rating. With a median terms of $110, the banal boasts an upside imaginable of astir 114%.

On November 5, Kristen Kluska, an expert astatine Cantor Fitzgerald, reiterated a ‘Buy’ standing connected Soleno Therapeutics, Inc. (SLNO), with a terms people of $123. Similarly, Kate Dellorusso from LifeSci Capital besides maintained the ‘Buy’ standing and a $110 terms target.

Cherries/Shutterstock.com

On the aforesaid day, Wells Fargo expert Derek Archila reduced his terms people connected the banal to $106 from $123, portion keeping an ‘Overweight’ rating. The expert believes Vykat XR volition beryllium a “$1B-plus cause successful Prader-Willi syndrome.”

Later connected November 17, Wolfe Research began sum of Soleno Therapeutics, Inc. (NASDAQ:SLNO) with an ‘Outperform’ standing and a $75 terms target, suggesting an upside imaginable of astir 44% from the existent price. This optimism surrounds the company’s caller FDA support of Vykat XR, which the expert regards arsenic “the lone approved therapy for hyperphagia successful PWS.” With the support of its Prader-Willi syndrome solution, Soleno Therapeutics, Inc. (NASDAQ:SLNO) is “entering a caller signifier of worth creation,” the probe steadfast stated.

Soleno Therapeutics, Inc. (NASDAQ:SLNO) is simply a California-based clinical-stage biopharmaceutical institution specializing successful caller therapeutics to dainty superior illnesses. Founded successful 1999, the institution provides Diazoxide Choline Extended-Release tablets.

While we admit the imaginable of SLNO arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.